Form 4: Cyclo Therapeutics Director Vivien Wong Receives Stock Grant in Lieu of Cash Compensation
SEC Form 4 Filing
Director Vivien Wong of Cyclo Therapeutics received 15,145 shares of common stock in lieu of cash compensation for the third quarter of 2024.
Summary
- Vivien Wong, a director at Cyclo Therapeutics, received 15,145 shares of common stock.
- This stock grant was in place of cash compensation for her role as a non-employee director.
- The grant covers compensation for the third quarter of 2024.
- The number of shares was calculated using a price of $0.66 per share, based on the closing price on November 14, 2024.
- Following the transaction, Ms. Wong directly owns 39,713 shares of common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders. There are no indications of any negative or unexpected events.
Positives
- The grant of shares to a director aligns their interests with those of shareholders.
- The use of stock instead of cash may help the company conserve cash resources.
Industry Context
This type of stock grant is a common practice for compensating non-employee directors, aligning their interests with the company's performance and shareholders.
Comparison to Industry Standards
- Stock grants are a typical form of compensation for non-employee directors across various industries.
- The practice of using the closing price of the stock on a specific date to calculate the number of shares is standard.
- Many companies, such as those in the biotechnology sector like Amgen or Regeneron, use similar methods for director compensation.
Stakeholder Impact
- Shareholders may view this as a positive as it aligns director interests with company performance.
- The use of stock instead of cash may be seen as a positive for the company's financial health.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Closing price of $0.66 per share used to calculate the number of shares granted. |
| 11/15/2024 | Date of the stock grant transaction. |
| 11/18/2024 | Date the Form 4 was signed. |
Keywords
Cyclo Therapeutics, Director Compensation, Stock Grant, Form 4, Vivien Wong, CYTH, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.